GlassScriptPhysician profile
Thea Klaas
NPI 1124456512
$2,116.51
in general payments reported to CMS, 2019-2025
16 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $139 · 2023: $687 · 2024: $894 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669 · Travel and Lodging: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,668.52 |
| Travel and Lodging | $308.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maquet Cardiovascular L.L.C. | $308.97 | 2024 | Vasoview Hemopro 2 |
| La Jolla Pharmaceutical Company | $260.18 | 2024 | Giapreza |
| Abiomed | $241.60 | 2023-2025 | Impella |
| Octapharma USA, INC. | $154.41 | 2025 | Fibryga |
| Medtronic, INC. | $149.89 | 2023 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $139.02 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $135.21 | 2023-2024 | Andexxa, Airsupra |
| Alexion Pharmaceuticals, INC. | $123.36 | 2023 | |
| Amgen INC. | $121.84 | 2025 | Uplizna |
| Eagle Pharmaceuticals, INC. | $116.69 | 2023 | |
| Abbvie INC. | $114.27 | 2024 | |
| Corcept Therapeutics | $102.70 | 2023 | Korlym |
| Teva Pharmaceuticals USA, INC. | $74.04 | 2024-2025 | Austedo Xr, Austedo Xr |
| Abbott Laboratories | $36.26 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.83 | 2025 | Jardiance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $15.24 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thea Klaas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.